Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice
Open Access

Spontaneous bacterial peritonitis in cirrhosis

Chirag Bhat, Jason Reinglas and Nicholas Costain
CMAJ January 23, 2023 195 (3) E120; DOI: https://doi.org/10.1503/cmaj.221090
Chirag Bhat
Department of Emergency Medicine (Bhat, Costain), University of Ottawa, Ottawa, Ont.; Scarborough Health Network (Reinglas), Scarborough, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Reinglas
Department of Emergency Medicine (Bhat, Costain), University of Ottawa, Ottawa, Ont.; Scarborough Health Network (Reinglas), Scarborough, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Costain
Department of Emergency Medicine (Bhat, Costain), University of Ottawa, Ottawa, Ont.; Scarborough Health Network (Reinglas), Scarborough, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Spontaneous bacterial peritonitis is a common complication of cirrhosis with high risk of death

Bacterial infection of ascites fluid, most commonly from Escherichia coli or Klebsiella pneumoniae, causes the condition.1 Its prevalence in patients with cirrhosis is 10.8% in North America, and nearly 25% of patients die despite appropriate antibiotic treatment.2

The presentation varies and patients may not have abdominal pain or fever

Spontaneous bacterial peritonitis is often a trigger for cirrhotic decompensation, which can manifest as isolated hepatic encephalopathy, gastrointestinal bleeding, renal failure, increasing ascites volume or any vital sign abnormalities, including hypothermia.1,3 Given its highly variable presentation, the current guideline recommends that every patient who presents urgently to hospital with cirrhosis and ascites be tested for the condition.1

Prompt diagnosis is required to reduce risk of death

A paracentesis that shows ascites fluid with a polymorphonuclear leukocyte count of 250 cells/mm3 (0.25 × 109/L) or greater confirms the diagnosis. In 1 study, delaying paracentesis by 12 hours resulted in a 2.7-fold increase in odds of death. Clinicians should perform paracentesis as soon as possible.4

Empiric antibiotic treatment requires consideration of local resistance patterns

In North America, antibiotic resistance in spontaneous bacterial peritonitis is 17.8%, with methicillin-resistant Staphylococcus aureus the most common resistant organism.2 Empiric treatment in low-resistance areas is a third-generation cephalosporin, and in high-resistance areas is piperacillin–tazobactam.1

Clinicians should prescribe albumin within 6 hours of diagnosis to confer a mortality benefit

Albumin has a number needed to treat of 6 patients to prevent 1 death, and of 4 patients to prevent 1 case of renal failure, if given within 6 hours of diagnosis of spontanous bacterial peritonitis.5 The latest guideline recommends that, in addition to fluid resuscitation, albumin be given to all patients with the condition.1 Recommended dosing is albumin 1.5 g/kg on day 1 and 1 g/kg on day 3.1

Footnotes

  • Competing interests: Jason Reinglas reports travel funding from Pfizer, and grants from Pfizer and Takeda for the Scarborough Health Network. No other competing interests were declared.

  • This article has been peer reviewed.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

References

  1. ↵
    1. Biggins SW,
    2. Angeli P,
    3. Garcia-Tsao G,
    4. et al
    . Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014–48.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Tay PWL,
    2. Xiao J,
    3. Tan DJH,
    4. et al
    . An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis. Front Med (Lausanne) 2021;8:693652.
    OpenUrl
  3. ↵
    1. Koulaouzidis A,
    2. Bhat S,
    3. Saeed AA
    . Spontaneous bacterial peritonitis. World J Gastroenterol 2009;15:1042–9.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Kim JJ,
    2. Tsukamoto MM,
    3. Mathur AK,
    4. et al
    . Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol 2014; 109:1436–42.
    OpenUrlPubMed
  5. ↵
    1. Salerno F,
    2. Navickis RJ,
    3. Wilkes MM
    . Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol 2013;11:123–30.e1.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 195 (3)
CMAJ
Vol. 195, Issue 3
23 Jan 2023
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Spontaneous bacterial peritonitis in cirrhosis
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Spontaneous bacterial peritonitis in cirrhosis
Chirag Bhat, Jason Reinglas, Nicholas Costain
CMAJ Jan 2023, 195 (3) E120; DOI: 10.1503/cmaj.221090

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Spontaneous bacterial peritonitis in cirrhosis
Chirag Bhat, Jason Reinglas, Nicholas Costain
CMAJ Jan 2023, 195 (3) E120; DOI: 10.1503/cmaj.221090
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Spontaneous bacterial peritonitis is a common complication of cirrhosis with high risk of death
    • The presentation varies and patients may not have abdominal pain or fever
    • Prompt diagnosis is required to reduce risk of death
    • Empiric antibiotic treatment requires consideration of local resistance patterns
    • Clinicians should prescribe albumin within 6 hours of diagnosis to confer a mortality benefit
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pneumopericardium as a complication of pericardiocentesis
  • A blistering variant of phlegmasia cerulea dolens from underlying squamous cell lung cancer
  • Parechovirus infections in infants
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Emergency medicine
    • Hepatology
    • Infectious diseases
    • Internal medicine
    • Sepsis

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire